PATENT CLAIM ANALYSIS

Application Number: 15867425
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "262100"]

Abstract:
The present invention concerns a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, where R 1 -R 3  and Y are defined in the description, and its use in the treatment of disorders in which pi3 kinase is implicated.

Claim (Index 3):
The method according to  claim 1 , wherein:\n R 1  is C 1 -C 3 -alkyl; R 2  is phenyl having the substitution pattern, wherein the R 2  phenyl is fused at R 4 -R 5 , R 5 -R 6 , R 6 -R 7  or R 7 -R 8  by a heteroaryl group selected from pyrazolyl, imidazoyl, oxazolyl, and isoxazolyl, where the fused heteroaryl group is independently optionally substituted by one or more groups selected from List X; List X represents hydroxyl, cyano, nitro, amino, C 1 -C 8 -alkylamino, di-C 1 -C 8 -alkylamino, or C 1 -C 8 -alkylamidino; R 3  is hydrogen; Y is \u2014NH 2 .

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14261890', '12180969', '12809394', '16060486', '14406848']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8002718461901134
- 35 USC 102 Novelty (BERT): 0.6148302850651968
- Combined Prediction Score: 0.7817276900776217
- Mean Citation Score: 441.36409
- Max Citation Score: 561.0378
- Similarity Product: 484.2235279337168

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test